Untangling the complexities of micropapillary cancer^†

Area of Science:

• Oncology
• Cell Biology
• Biophysics

Background:

• Distinct morphological subtypes of colorectal cancer (CRC) are associated with poor prognosis.
• Micropapillary cancer (MPC) is a highly aggressive CRC subtype with a bleak clinical outlook.
• Understanding the mechanisms driving MPC morphology is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the morphological evolution of micropapillary colorectal cancer (MPC).
• To identify the molecular and biophysical mechanisms regulating MPC development.
• To explore the potential for reversing MPC morphology through targeted interventions.

Main Methods:

• Utilized three-dimensional (3D) patient-derived colorectal cancer tissue-originated spheroids (CTOSs) for iterative modeling.
• Investigated spatiotemporal oscillations of Rho-ROCK signaling.
• Validated findings in CTOSs, xenografts, and archival human CRC samples.

Main Results:

• Rho-ROCK hyperactivity was identified as a key driver of reversed membrane polarity and suppressed lumen formation in MPC development.
• Targeted inhibition of Rho-ROCK activity successfully restored membrane polarity and lumen formation in 3D CTOS cultures and xenografts.
• These findings demonstrate that cancer morphology, previously considered irreversible, can be modulated.

Conclusions:

• The study elucidates molecular, biophysical, and multicellular mechanisms underlying the morphological evolution of micropapillary colorectal cancer.
• Targeting Rho-ROCK signaling presents a potential therapeutic strategy to reverse the aggressive MPC phenotype.
• This research enhances the understanding of MPC biology and offers new insights into cancer behavior and treatment.